Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $73.0200 (-1.68%) ($69.9900 - $77.7100) on Tue. Mar. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.88% (three month average) | RSI | 36 | Latest Price | $73.0200(-1.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -3.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -4.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(52%) DIA(51%) IVE(50%) | Factors Impacting ABBV price | ABBV will decline at least -1.44% in a week (0% probabilities). VIXM(-36%) VXX(-13%) TLT(-13%) UUP(-1%) IGOV(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.44% (StdDev 2.88%) | Hourly BBV | -1.2 () | Intraday Trend | -3.9% | | | |
|
Inflection Point | Yes | Resistance Level | $86.76 | 5 Day Moving Average | $79.22(-7.83%) | 10 Day Moving Average | $83.66(-12.72%) | 20 Day Moving Average | $86.76(-15.84%) | To recent high | -25.3% | To recent low | 0% | Market Cap | $128.828b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |